Table 2 The clinical characteristics about RUNX1 expression in KIRC patients.
From: Expression patterns and prognostic value of RUNX genes in kidney cancer
Characteristic | RUNX1FPKM | % | |
|---|---|---|---|
Numbers of patients, n | 531 | ||
Median age, years | 61 (26–90) | ||
Gender, n | |||
Male | 344 | 4.00 (0.1–36.5) | 64.78 |
Female | 187 | 3.10 (0.5–15.7) | 35.22 |
Age, n | |||
< 65 years | 332 | 3.60 (0.3–36.5) | 62.52 |
≥ 65 years | 199 | 3.55 (0.1–19.8) | 37.48 |
Race, n | |||
White | 462 | 3.70 (0.2–36.5) | 87.01 |
Non-white | 64 | 2.95 (0.5–11.1) | 12.05 |
Not known | 5 | 1.80 | 0.94 |
TNM Stage, n | |||
Stage I + II | 324 | 3.20 (0.1–21.9) | 61.02 |
Stage III + IV | 207 | 4.40 (0.5–36.5) | 38.98 |
Grade, n | |||
Grade I + II | 243 | 3.26 (0.21–21.9) | 45.76 |
Grade III + IV | 282 | 4.95 (0.7–36.5) | 53.11 |